These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8445195)

  • 1. Orphenadrine poisoning and review of physostigmine.
    Clark RF
    J Emerg Med; 1993; 11(1):97. PubMed ID: 8445195
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of orphenadrine-induced ventricular tachycardia with physostigmine.
    Danze LK; Langdorf MI
    J Emerg Med; 1991; 9(6):453-7. PubMed ID: 1787292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of physostigmine on respiratory and circulatory changes caused by overdoses of orphenadrine or imipramine in the rat.
    Zandberg P; Sangster B
    Acta Pharmacol Toxicol (Copenh); 1982 Mar; 50(3):185-95. PubMed ID: 7090842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orphenadrine overdose treated with physostigmine.
    Snyder BD; Kane M; Plocher D
    N Engl J Med; 1976 Dec; 295(25):1435. PubMed ID: 980101
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report: orphenadrine overdose cerebral manifestations treated with physostigmine.
    Bennett NB; Kohn J
    Anaesth Intensive Care; 1976 Feb; 4(1):67. PubMed ID: 1251997
    [No Abstract]   [Full Text] [Related]  

  • 6. [Delirium due to orphrnadine chloride treated with physostigmine salicylate].
    Klauber PV
    Ugeskr Laeger; 1976 Jan; 138(4):225-6. PubMed ID: 1251484
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of orphenadrine overdose.
    Sangster B; van Heijst AN; Zimmerman AN
    N Engl J Med; 1977 Apr; 296(17):1006. PubMed ID: 846533
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter: Antidotes for drug overdose.
    Mendelson G
    Anaesth Intensive Care; 1975 Aug; 3(3):268-9. PubMed ID: 1166956
    [No Abstract]   [Full Text] [Related]  

  • 9. Orphenadrine poisoning in a child: clinical and analytical data.
    Van Herreweghe I; Mertens K; Maes V; Ramet J
    Intensive Care Med; 1999 Oct; 25(10):1134-6. PubMed ID: 10551971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Orphenadrine poisoning].
    Munk-Jørgensen P; Kold AV
    Ugeskr Laeger; 1981 Mar; 143(12):753. PubMed ID: 7292637
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug interaction? Orphenadrine with propoxyphene.
    Pearson RE; Salter FJ
    N Engl J Med; 1970 May; 282(21):1215. PubMed ID: 5427314
    [No Abstract]   [Full Text] [Related]  

  • 12. [Letter: Physostigmine therapy in poisoning].
    von Mühlendahl KE; Krienke EG
    Dtsch Med Wochenschr; 1976 Sep; 101(38):1401-2. PubMed ID: 954602
    [No Abstract]   [Full Text] [Related]  

  • 13. Postoperative orphenadrine withdrawal.
    Esler MD; Pratt ME; Brunner MD
    Br J Anaesth; 2000 Sep; 85(3):497. PubMed ID: 11103206
    [No Abstract]   [Full Text] [Related]  

  • 14. Intestinal obstruction complicating orphenadrine treatment.
    Daggett P; Ibrahim SZ
    Br Med J; 1976 Jan; 1(6000):21-2. PubMed ID: 1247718
    [No Abstract]   [Full Text] [Related]  

  • 15. Physostigmine. Antidote for anticholinergic poisoning.
    Snyder BD
    Minn Med; 1975 Jun; 58(6):456-7. PubMed ID: 1143251
    [No Abstract]   [Full Text] [Related]  

  • 16. Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.
    Luzza F; Raffa S; Saporito F; Oreto G
    Int J Clin Pract; 2006 May; 60(5):606-8. PubMed ID: 16700864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physostigmine and the anticholinergic syndrome. Treatment of postanesthetic delirium and stupor and certain types of poisoning].
    Christensen P; Modvig KM
    Ugeskr Laeger; 1979 Jan; 141(5):287-9. PubMed ID: 760309
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute poisoning with tricylic antidepressants and treatment with physostigmine salicylate (author's transl)].
    Czech K; Francesconi M; Haimböck E; Hruby K
    Wien Klin Wochenschr; 1977 Apr; 89(8):265-9. PubMed ID: 855346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-sustained ventricular tachycardia due to low-dose orphenadrine.
    Dilaveris P; Pantazis A; Vlasseros J; Gialafos J
    Am J Med; 2001 Oct; 111(5):418-9. PubMed ID: 11599527
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Physostigmine: rational use.
    Rumack BH
    JACEP; 1976 Jul; 5(7):541-2. PubMed ID: 940245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.